ESCAPE NONO NA-1-009

A multicenter, randomized, double-blinded, placebo controlled, parallel group, single-dose design to determine the efficacy and safety of nerinetide in participants with acute ischemic stroke undergoing dndovascular thrombectomy excluding thrombolysis

The purpose of this study is to evaluate the efficacy and safety of Nerinetide in patients with acute ischemic stroke undergoing endovascular thrombectomy.